ClearPoint Neuro Inc. (CLPT) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to the ClearPoint Neuro, Inc. fourth quarter and full year 2025 Financial Results Conference call. At this time, all participants are on a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the call, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. Comments made on this call may include statements that are forward-looking within the meaning of securities laws. These full-looking statements may include, without limitation, statements related to anticipated industry trends, the company's plans, prospects, and strategies, both preliminary and projected, besides the total adjustable markets or the market opportunity for the company's products and services. the company's expectations regarding the integration, performance, and anticipated benefits of its recent acquisition of Eris Holdings Inc., including operational efficiencies and the impact of the company's financial condition and results of operations, the company's expectation for future development, regulatory approval, timing, commercialization, and the market for cell and gene therapies, and the anticipated adoption of the company's products and services for use in the delivery of gene and cell therapies, and management's expectations, beliefs, estimates, or projections regarding future revenue and results of operations. You are cautioned not to place undue reliance on forward-looking statements which speak only as of the date on which they were made. Actual results or trends could differ materially. The company undertakes no obligation to revise forward-looking statements or new information or future events. For more information about the company's risks a...